Fate Therapeutics, Inc. (FATE) was a big mover last session with its shares rising roughly 7% on the day. This led to far more shares changing hands yesterday than in a normal session. This breaks the recent trend of the company as the stock is now trading above the past one month’s volatile price range of $5.80 to $6.30.
This clinical-stage biopharmaceutical company has seen no estimate revision in the last 30 days. However, the Zacks Consensus Estimate has moved down over the same period. This implies trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s rally can last.
Fate Therapeutics currently has a Zacks Rank #4 (Sell) and its Earnings ESP is 0.00%.
A stock worth considering in the Med-Biomed/Genetic space is Cambrex Corporation (CBM) with a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment